ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — ImmunoForge announced that it…

DJI Launches All-in-One Vlog Camera Drone with DJI Flip

New DJI Flip is DJI’s first drone to feature foldable, full-coverage propeller…

MINISO Group Announces Completion of US$550 Million Equity Linked Securities

GUANGZHOU, China, Jan. 14, 2025 /PRNewswire/ — MINISO Group Holding Limited (NYSE:…

Bybit Card Partners with Entravel to Bring Discounted Luxury Travel to Its Users

DUBAI, UAE, Jan. 14, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…

The Bicester Collection Brings the Unlock Her Future™ Prize 2025 to South Asia to Support the Next Wave of Female Social Entrepreneurs

For its third edition, the annual entrepreneurship programme aims to drive change…

Smartkem Recaps 2024 Achievements and Sets 2025 Goals

MANCHESTER, England, Jan. 14, 2025 /PRNewswire/ — Smartkem (Nasdaq: SMTK), which is…

Grand Sunergy: Be Member of Taklamakan Desert Encirclement Project's Solar Wall

NANJING, China, Jan. 14, 2025 /PRNewswire/ — In November, China has successfully encircled…

AI must be better integrated into investment process, new buy-side survey by SimCorp shows

Key findings in the 2025 InvestOps report: A new report surveying 200…